1673-4157
2012 Issue 5
Insulin resistance and its risk factors in different degree of fatty liver in patients with NAFLD
YANG Ju-hong;WANG Hua;SUN Li-rong
YANG Ju-hong;WANG Hua;SUN Li-rong
..............page:291-294
The mechanism and target for anti-osteoporostic drugs
HONG Wei;ZHU Han-min
HONG Wei;ZHU Han-min
..............page:351-354
Effects of GLP-1 receptor agonists on insulin sensitivity
ZHENG Ren-dong;LIU Chao
ZHENG Ren-dong;LIU Chao
..............page:318-320
Mechanisms of anti-inflammatory effects of insulin
JIANG Dong-dong;HAN Ting-ting;HU Yao-min
JIANG Dong-dong;HAN Ting-ting;HU Yao-min
..............page:331-334
Autoimmune and diabetic macrovascular complications
ZENG Ting;JIANG Xiao-zhen
ZENG Ting;JIANG Xiao-zhen
..............page:348-350
Expression of secretory leukocyte protease inhibitor in rats with polycystic ovary syndrome
ZHOU Li-lan;LIU Ji-xiao;MA Bao-rong;LIN Wan-jun
ZHOU Li-lan;LIU Ji-xiao;MA Bao-rong;LIN Wan-jun
..............page:299-302,封2
Advanced glycation end products and diabetic osteoporosis
YANG Li;CHENG Yan-zhen;CAI De-hong
YANG Li;CHENG Yan-zhen;CAI De-hong
..............page:355-357
Targeted differentiation of stem cells induced by glucagon-like peptide-1
SHAO Zhu-lin;XU Xiang-jin;CHEN Pin
SHAO Zhu-lin;XU Xiang-jin;CHEN Pin
..............page:314-317
The mechanism and clinical effects of exenatide
DING Shao-feng;YANG Xing-lin;SUN Feng-juan
DING Shao-feng;YANG Xing-lin;SUN Feng-juan
..............page:321-323,327
Estrogen and diabetic encephalopathy
PAN Ling;LUO Min;XIAO Qian
PAN Ling;LUO Min;XIAO Qian
..............page:341-343
Role of microRNA-29 in diabetes mellitus and its complications
CHANG Ying;ZHANG Xing-ping
CHANG Ying;ZHANG Xing-ping
..............page:338-340
Islet autoimmunity and type 2 diabetes
ZHOU Hong;XIANG Ming
ZHOU Hong;XIANG Ming
..............page:335-337
L-cell function and regulatory mechanism in obesity
SU Jing;LI Xiao-hua
SU Jing;LI Xiao-hua
..............page:324-327
Current progress of G protein coupled receptor 119 agonists
WANG Yi-feng;XIANG Jie;BU Rui-fang
WANG Yi-feng;XIANG Jie;BU Rui-fang
..............page:328-330
The technique of debridement in the treatment of diabetic foot ulcers
CHEN Yin-chen;WANG Wei;YANG Jun-sheng;JIANG Ke-chun;WANG Ai-ping
CHEN Yin-chen;WANG Wei;YANG Jun-sheng;JIANG Ke-chun;WANG Ai-ping
..............page:309-310,313
Novel adipocytokines and diabetic nephropathy
YU Qiu-xia;ZHANG Hui-juan;HAO Fei;BAI Meng-meng
YU Qiu-xia;ZHANG Hui-juan;HAO Fei;BAI Meng-meng
..............page:344-347
Introduction of the 2012 Infectious Disease Society of America "clinical practice guideline for the diagnosis and treatment of diabetic foot infections"
XU Zhang-rong;WANG Yu-zhen
XU Zhang-rong;WANG Yu-zhen
..............page:303-305
Effects of long term health education on diabetic complications
HUANG Zhao-sui;LIU Liang;HE Yi-fen;HUANG Zhao-xuan;YIN Ting-ting;SU Xiao-yan;LUAN Li-li;WANG Gui-guo
HUANG Zhao-sui;LIU Liang;HE Yi-fen;HUANG Zhao-xuan;YIN Ting-ting;SU Xiao-yan;LUAN Li-li;WANG Gui-guo
..............page:295-298
The role of vacuum sealing drainage in the treatment of diabetic foot
LUO Ning;LIU Lan;WANG Wei;SUN Xin-juan;WANG Ai-ping
LUO Ning;LIU Lan;WANG Wei;SUN Xin-juan;WANG Ai-ping
..............page:311-313
Transcriptional control of adipogenesis-toward a new generation of therapeutics for metabolic disease
YANG Jin-kui
YANG Jin-kui
..............page:289-290,294
Epidemiological investigation of diabetes in the Tianjin Dagang Oilfield
LIU Yan;HAN Ying;LI Rui-xia;SHI Jie-li;XU Fu-juan;LONG Xue;JIN Na-na;LI Su-fen;GAO Peng-fei;LIANG Hang
LIU Yan;HAN Ying;LI Rui-xia;SHI Jie-li;XU Fu-juan;LONG Xue;JIN Na-na;LI Su-fen;GAO Peng-fei;LIANG Hang
..............page:358-360
The diagnosis and treatment of diabetic foot infections
WANG Wei;CHEN Yin-chen;JIANG Ke-chun;SUN Jin-shan;WANG Ai-ping
WANG Wei;CHEN Yin-chen;JIANG Ke-chun;SUN Jin-shan;WANG Ai-ping
..............page:306-308